NCT02451748 | University of Illinois at Chicago|UCB Pharma | Rheumatoid Arthritis | August 2015 | Phase 4 |
NCT05463367 | Northwestern University|Shirley Ryan AbilityLab|National Institutes of Health (NIH) | Opioid Use|Opioid Dependence|Opioid-use Disorder|Narcotic Use|Back Pain|Back Injuries|Chronic Pain|Chronic Low-back Pain|Pain, Chronic|Pain;Back Low;Chronic|Pain, Back | January 1, 2021 | Phase 2 |
NCT01404598 | NicOx | Pharmacokinetics | January 2010 | Phase 1 |
NCT04639804 | HK inno.N Corporation | Healthy | June 6, 2020 | Phase 1 |
NCT00907400 | AstraZeneca | Healthy | May 2009 | Phase 1 |
NCT00966641 | PLx Pharma|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Healthy Volunteers | August 2009 | Phase 1|Phase 2 |
NCT05087914 | Northwestern University|Northwestern Medical Group|National Institutes of Health (NIH) | Acute Pain|Bunionectomy|Toe Fusion | November 1, 2021 | Phase 2 |
NCT01471886 | EMS | Back Pain | March 2013 | Phase 3 |
NCT02255955 | Diskapi Yildirim Beyazit Education and Research Hospital | Postoperative Pain|Postoperative Laminectomy Pain | October 2014 | Phase 4 |
NCT00222976 | University of Saskatchewan|Saskatoon Health Region | Post-Vaginal Delivery Perineal Pain | September 2006 | Phase 4 |
NCT02786446 | Shifa International Hospital | Renal Stone | July 2015 | Not Applicable |
NCT03794219 | Ankara Education and Research Hospital | Lateral Epicondylitis | January 7, 2019 | Not Applicable |
NCT00004845 | National Institute on Aging (NIA)|Alzheimer´s Disease Cooperative Study (ADCS) | Alzheimer Disease | | Phase 2|Phase 3 |
NCT04183556 | Batman Training and Research Hospital | Primary Dysmenorrhea | November 15, 2019 | Not Applicable |
NCT01358383 | AstraZeneca | Juvenile Idiopathic Arthritis | May 2011 | Phase 1 |
NCT04307940 | Bayer | Pain | March 12, 2020 | Phase 4 |
NCT04145518 | NorthShore University HealthSystem|National Institutes of Health (NIH)|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Dysmenorrhea (Disorder)|Dysmenorrhea Primary|Dysmenorrhea Secondary|Endometrial Diseases|Leiomyoma|Fibroid Uterus | October 25, 2019 | Phase 4 |
NCT00137033 | Pfizer´s Upjohn has merged with Mylan to form Viatris Inc.|Pfizer | Peptic Ulcers | September 2004 | Phase 4 |
NCT04499209 | Xgene Pharmaceutical Group | Pain | October 16, 2017 | Phase 1 |
NCT03183297 | Sen-Jam Pharmaceutical | Veisalgia | August 2017 | Phase 1 |
NCT01994226 | Keele University | Gout | January 2014 | Phase 4 |
NCT00789802 | Washington University School of Medicine|American College of Obstetricians and Gynecologists | Contraception|Bleeding | November 2008 | Not Applicable |
NCT02408978 | Oxford Pharmascience Ltd | Gastroduodenal Erosions | May 2015 | Phase 1 |
NCT05026320 | Bayer|Deutsche Sporthochschule Köln | Soft Tissue Injury | August 8, 2021 | Phase 2 |
NCT01383486 | Bayer | Pain | July 2011 | Phase 3 |
NCT01129011 | POZEN | Gastric Ulcer | September 2007 | Phase 3 |
NCT00346216 | Pfizer´s Upjohn has merged with Mylan to form Viatris Inc.|The Cleveland Clinic|Pfizer | Arthritis, Rheumatoid | October 4, 2006 | Phase 4 |
NCT04132336 | Bayer | Pain, Postoperative | November 12, 2019 | Phase 2 |
NCT02139046 | Takeda | Gout | April 2014 | Phase 3 |
NCT00876187 | Pfizer | Low Back Pain | June 15, 2009 | Phase 2 |
NCT00818415 | Bayer | Pain | November 2008 | Phase 1 |
NCT01118273 | Bayer | Sleep | January 2008 | Phase 4 |
NCT00743587 | Pfizer | Osteoarthritis Thumbs | September 2008 | Phase 1 |
NCT01427803 | Bayer | Pain | September 2011 | Phase 3 |
NCT02463552 | Universidade Federal de Sergipe | Toothache|Tooth Bleaching | May 2015 | Not Applicable |
NCT02252614 | Diskapi Yildirim Beyazit Education and Research Hospital | Postoperative Pain, PCA Contramal Consumption | September 2014 | Phase 4 |
NCT01939002 | Biogen | Relapsing Multiple Sclerosis | November 2013 | Phase 3 |
NCT03697720 | NorthShore University HealthSystem | Dysmenorrhea|Pain | May 9, 2018 | Phase 4 |
NCT01052792 | Dr. Reddy´s Laboratories Limited | Healthy | May 2006 | Phase 1 |
NCT00804401 | Perrigo Company | Bioequivalency | June 2004 | Phase 1 |
NCT03028870 | Purdue Pharma LP|Shionogi | Osteo Arthritis Knee | March 14, 2017 | Phase 2 |
NCT00665743 | POZEN | Arthritis | March 2008 | Phase 1 |
NCT00157872 | Merck Sharp & Dohme LLC | Rheumatoid Arthritis | January 7, 2004 | Phase 4 |
NCT05541185 | Sultan �E�EN|Mersin University | Knee Osteoarthritis | February 15, 2021 | Not Applicable |
NCT00778193 | Research Associates of New York, LLP | Gastroduodenal Ulcer | October 2007 | Phase 4 |
NCT03949673 | Regeneron Pharmaceuticals|Teva Pharmaceutical Industries, Ltd. | Osteoarthritis, Knee|Osteoarthritis, Hip | April 8, 2019 | Phase 2 |
NCT00928837 | Primus Pharmaceuticals | Osteoarthritis | March 2006 | Not Applicable |
NCT01071317 | Montefiore Medical Center | Migraine | February 2010 | Phase 4 |
NCT00433732 | POZEN | Migraine Headaches | August 2004 | Phase 3 |
NCT03291418 | Antibe Therapeutics Inc. | Gastric Ulcer | September 8, 2017 | Phase 1|Phase 2 |
NCT02986334 | Apkar Apkarian|National Center for Complementary and Integrative Health (NCCIH)|National Institutes of Health (NIH)|Northwestern University | Chronic Low Back Pain | August 2016 | Phase 4 |
NCT04038346 | Desiree Neville, MD|University of Pittsburgh | Lyme Arthritis|Lyme Disease|Arthritis | October 1, 2019 | Phase 3 |
NCT04572828 | Ege University | Office-based Endometrial Sampling Procedures | September 28, 2020 | Not Applicable |
NCT02128490 | Takeda | Gout|Moderate Renal Impairment | May 2014 | Phase 2 |
NCT01280591 | Bayer | Pain, Postoperative | October 2010 | Phase 3 |
NCT02116790 | Northwestern University|National Institute of Dental and Craniofacial Research (NIDCR)|National Institutes of Health (NIH) | Acute Pain | May 2014 | Phase 2 |
NCT05995912 | Laboratorios Liomont|Infinite Clinical Research, S.A. de C.V. | Acute Pain|Postoperative Pain | September 29, 2021 | Phase 2 |
NCT05629494 | Albany Medical College | Prostate Cancer|Prostate Inflammation|PSA | September 27, 2022 | Phase 4 |
NCT02667730 | Canadian Department of National Defense | Ligament Injury | June 2015 | Phase 4 |
NCT00279747 | Boehringer Ingelheim | Arthritis, Juvenile Rheumatoid | September 2000 | Phase 3 |
NCT01525043 | International Clinical Research Institute | Epicondylitis of the Elbow | February 2012 | Phase 4 |
NCT01090596 | Research Associates of New York, LLP | Healthy | April 2007 | Not Applicable |
NCT05851976 | Montefiore Medical Center | Back Pain, Low | August 2023 | Phase 4 |
NCT00844805 | Merck Sharp & Dohme LLC | Ankylosing Spondylitis|Axial Spondyloarthritis | September 2009 | Phase 3 |
NCT01390324 | Ache Laboratorios Farmaceuticos S.A. | Migraine|Headache | December 2011 | Phase 3 |
NCT00981357 | Pfizer | Osteoarthritis, Knee | November 2009 | Phase 2 |
NCT01365052 | Bayer | Pain | May 2011 | Phase 3 |
NCT05485805 | Bayer | Postoperative Dental Pain | September 21, 2022 | Phase 3 |
NCT04066426 | Yuzuncu Y?l University | Temporomandibular Disorder | March 1, 2018 | Phase 4 |
NCT04325633 | Assistance Publique - Hôpitaux de Paris | COVID-19 | April 24, 2020 | Phase 3 |
NCT04015596 | Massachusetts General Hospital | PANDAS|Anxiety Disorder|Autoimmune Diseases|Obsessive-Compulsive Disorder | October 20, 2020 | Phase 4 |
NCT01952652 | Baskent University | Arthroscopic Meniscus Surgery | January 2013 | Phase 4 |
NCT00504127 | NicOx | Osteoarthritis | April 2007 | Phase 3 |
NCT00830063 | Pfizer | Arthritis|Osteoarthritis | May 5, 2009 | Phase 3 |
NCT00803764 | Perrigo Company | Bioequivalency | June 2004 | Phase 1 |
NCT00366262 | Wyeth is now a wholly owned subsidiary of Pfizer | Healthy | June 2006 | Phase 1 |
NCT03472469 | The University of Texas Health Science Center, Houston|National Center for Advancing Translational Sciences (NCATS) | Nonspecific Pain Post Traumatic Injury | April 2, 2018 | Phase 4 |
NCT02519231 | University of Washington|Cook County Hospital|Teva Pharmaceuticals USA | Menorrhagia | February 2016 | Phase 4 |
NCT00909519 | NicOx | Renal Hemodynamics | January 2009 | Phase 1 |
NCT00643799 | Pfizer´s Upjohn has merged with Mylan to form Viatris Inc.|Pfizer | Osteoarthritis, Knee | March 2004 | Phase 4 |
NCT01982799 | University of Minnesota | Odontalgia | February 2014 | Not Applicable |
NCT04947566 | Fatima Memorial Hospital | Pain, Postoperative | September 2, 2019 | Phase 4 |
NCT03161093 | Regeneron Pharmaceuticals|Teva Pharmaceutical Industries, Ltd. | Osteoarthritis, Knee|Osteoarthritis, Hip | August 17, 2017 | Phase 3 |
NCT00503828 | Mahidol University|Ministry of Health, Thailand | Knee Osteoarthritis | July 2007 | Phase 3 |
NCT03424135 | Bayer | Clinical Pharmacology | March 2, 2018 | Phase 1 |
NCT02281968 | Northwell Health | Closed Fracture of Ankle | December 2014 | Phase 4 |
NCT05982392 | Dow University of Health Sciences | Symptomatic Irreversible Pulpitis|Post Operative Pain | March 1, 2023 | Phase 2|Phase 3 |
NCT01442428 | University of Minnesota|Pfizer|Minnesota Medical Foundation | Immune Reconstitution Inflammatory Syndrome|Immune Reconstitution Syndrome|Tuberculosis|HIV-infection+Aids | January 2014 | Phase 2|Phase 3 |
NCT02847702 | Purdue Pharma LP | Osteoarthritis Pain of the Knee | August 2016 | Phase 2 |
NCT03404206 | Bayer | Pain, Postoperative | February 12, 2018 | Phase 4 |
NCT02712957 | Neomed Institute | Pain|Osteoarthritis of the Knee | March 2016 | Phase 2 |
NCT01688934 | Purdue Pharma LP | Osteoarthritis, Knee|Pain | September 2012 | Phase 2 |
NCT00586365 | Massachusetts General Hospital | Heterotopic Ossification | October 2007 | Phase 4 |
NCT00652925 | Pfizer | Arthritis, Juvenile Rheumatoid | October 2002 | Phase 3 |
NCT02388191 | Planned Parenthood League of Massachusetts | Contraception | April 2015 | Not Applicable |
NCT02611466 | Astellas Pharma Europe B.V.|Astellas Pharma Inc | Osteoarthritis of the Knee|Chronic Lower Back Pain | February 16, 2016 | Phase 2 |
NCT01131767 | Dr. Reddy´s Laboratories Limited | Healthy | July 2004 | Phase 1 |
NCT05237297 | Il-Yang Pharm. Co., Ltd. | Drug Interaction Potentiation | February 17, 2022 | Phase 1 |
NCT00153660 | Chinese University of Hong Kong | Arthritis|Cardiovascular Diseases|Cerebrovascular Disorders | June 2005 | Phase 3 |
NCT01331993 | AstraZeneca | Healthy Volunteers|Bioequivalence | September 2011 | Phase 1 |
NCT05411718 | M.D. Anderson Cancer Center|National Institutes of Health (NIH)|National Cancer Institute (NCI) | T Cells|Colorectal Cancer|Lynch Syndrome | November 25, 2023 | Phase 2 |
NCT00913627 | Pfizer | Pain | May 7, 2009 | Phase 2 |
NCT01666678 | Bayer | Therapeutic Equivalence | January 2012 | Phase 1 |
NCT03699293 | Inova Health Care Services | Rheumatoid Arthritis|Cardiovascular Diseases | September 22, 2018 | Phase 4 |
NCT00751556 | Bayer | Healthy | February 2008 | Phase 1 |
NCT01389284 | Bayer | Pain, Postoperative | June 2011 | Phase 3 |
NCT01495858 | Bayer | Pain, Postoperative | December 2011 | Phase 3 |
NCT01659372 | Shahid Beheshti University | TMD | June 2012 | Phase 1 |
NCT03401177 | Bispebjerg Hospital | Tendon Injuries|Achilles Tendinopathy|Inflammation | January 15, 2018 | Not Applicable |
NCT01557816 | Analgesic Solutions | Osteoarthritis, Knee | December 2011 | Not Applicable |
NCT00434083 | POZEN | Migraine Headaches | July 2004 | Phase 3 |
NCT02522130 | Al Hayat National Hospital|Menoufia University | IUD Insertion Complication | July 2015 | Not Applicable |
NCT05154682 | Rothman Institute Orthopaedics | Pain, Postoperative | November 30, 2021 | Phase 3 |
NCT00650455 | Pfizer | Arthritis, Rheumatoid | February 2003 | Phase 4 |
NCT00418782 | Pfizer | Osteoarthritis | January 2007 | Phase 2 |
NCT02502006 | University of Pennsylvania|National Heart, Lung, and Blood Institute (NHLBI) | Healthy | November 2015 | Phase 1 |
NCT00034853 | Boehringer Ingelheim | Arthritis, Juvenile Rheumatoid | December 2000 | Phase 3 |
NCT00541489 | NicOx | Osteoarthritis|Osteoarthritis, Hip | June 2007 | Phase 3 |
NCT02108548 | Astellas Pharma Europe B.V.|Astellas Pharma Inc | Pharmacokinetics of ASP7657|Pharmacodynamics of ASP7657|Healthy Subjects | April 2014 | Phase 1 |
NCT02052908 | National Cancer Institute (NCI) | Lynch Syndrome | January 27, 2014 | Phase 1 |
NCT01612975 | McMaster University|McMaster Surgical Associates | Pleural Effusion|Pleural Effusion Malignant | April 2014 | Phase 2 |
NCT00652808 | Pfizer | Osteoarthritis|Knee | May 2004 | Phase 3 |
NCT01726920 | Ache Laboratorios Farmaceuticos S.A. | Migraine|Headache | July 2014 | Phase 3 |
NCT05161221 | Rothman Institute Orthopaedics | Pain, Postoperative|ACL | December 6, 2021 | Phase 3 |
NCT04490434 | Daewoong Pharmaceutical Co. LTD. | Healthy Male Volunteers | June 19, 2020 | Phase 1 |
NCT01468025 | Targeted Medical Pharma | Low Back Pain | February 2009 | Phase 3 |
NCT00601458 | Merck Sharp & Dohme LLC | Acute Pain | July 2007 | Phase 1 |
NCT01160822 | Novartis Pharmaceuticals|Novartis | Osteoarthritis | April 2010 | Phase 2 |
NCT03658473 | Galeno Desenvolvimento de Pesquisas Clínicas|Biolab Sanus Farmaceutica | Gastric Lesion | November 12, 2014 | Phase 3 |
NCT00761501 | AstraZeneca | Healthy Volunteer | September 2008 | Phase 1 |
NCT04449471 | University of Washington|Oregon Health and Science University|National Institute of General Medical Sciences (NIGMS) | Pharmacogenetics | January 12, 2016 | Phase 4 |
NCT00659490 | AstraZeneca | Pain | February 2008 | Phase 2 |
NCT01208207 | Organon and Co | Spondylitis, Ankylosing | September 27, 2010 | Phase 3 |
NCT01539447 | University of Utah | Heterotopic Ossification | January 2012 | Early Phase 1 |
NCT00410995 | University of Oklahoma | Healthy | May 2004 | Phase 4 |
NCT00807846 | Pfizer´s Upjohn has merged with Mylan to form Viatris Inc.|Pfizer | Arthritis, Juvenile Rheumatoid | September 2009 | Phase 4 |
NCT02632812 | Biolab Sanus Farmaceutica | Gastrointestinal Lesions | October 2014 | Phase 1 |
NCT02202512 | Boehringer Ingelheim | Healthy | September 2014 | Phase 1 |
NCT01107236 | Ironwood Pharmaceuticals, Inc. | Healthy | June 2010 | Phase 2 |
NCT00780325 | University of Pennsylvania|CrystalGenomics, Inc. | Healthy Volunteers | October 2008 | Phase 1 |
NCT01102660 | Pfizer | Osteoarthritis | May 2010 | Phase 2 |
NCT01154790 | CrystalGenomics, Inc. | Healthy | June 2010 | Phase 1 |
NCT00626275 | Cubist Pharmaceuticals LLC | Rheumatoid Arthritis | October 2007 | Phase 2 |
NCT00826462 | University of Oslo|Allmennmedisinsk forskningsfond, Norway | Tennis Elbow|Epicondylitis, Lateral Humeral | March 2009 | Phase 4 |
NCT00945178 | AstraZeneca | Healthy Volunteers | August 2009 | Phase 1 |
NCT02549469 | Bayer | Pain | March 2007 | Phase 1 |
NCT03771612 | University of California, Los Angeles | Inflammation | February 9, 2022 | Early Phase 1 |
NCT01139190 | PLx Pharma|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Gastroduodenal Ulcerations|Erosion | July 2010 | Phase 2 |
NCT03566979 | Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division|Johnson & Johnson Consumer and Personal Products Worldwide | Post-operative Dental Pain | August 13, 2018 | Phase 3 |
NCT00387881 | GlaxoSmithKline | Migraine, Without Aura | September 2006 | Phase 3 |
NCT01995006 | University Hospital, Basel, Switzerland | Healthy | January 2014 | Phase 1 |
NCT01670552 | EMS | Acute and Chronic Inflammation|Dyspepsia | February 17, 2016 | Phase 3 |
NCT00648258 | Pfizer | Osteoarthritis | July 2003 | Phase 3 |
NCT01178203 | Azad University of Medical Sciences | Pulpitis|Pain Management | July 2010 | Phase 1|Phase 2 |
NCT03092193 | University of Sao Paulo|Fundação de Amparo à Pesquisa do Estado de São Paulo | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant|Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant | March 1, 2017 | Phase 4 |
NCT01207115 | AbbVie (prior sponsor, Abbott)|AbbVie | Osteoarthritis of the Knee | September 2010 | Phase 2 |
NCT05761574 | Johnson & Johnson Consumer Inc. (J&JCI)|Johnson & Johnson Consumer and Personal Products Worldwide | Pain | May 22, 2023 | Phase 3 |
NCT00969449 | Bayer | Pharmacokinetics | April 2009 | Phase 1 |
NCT01229228 | Iroko Pharmaceuticals, LLC | Dental Pain | October 2010 | Phase 2 |
NCT02769247 | Walter Reed National Military Medical Center | Contraception|Pain | June 2014 | Not Applicable |
NCT00303017 | Primus Pharmaceuticals | Osteoarthritis | March 2006 | Not Applicable |
NCT04384367 | Eurofarma Laboratorios S.A. | Migraine | December 30, 2022 | Phase 3 |
NCT00007189 | Seattle Institute for Biomedical and Clinical Research|National Institute on Aging (NIA)|VA Puget Sound Health Care System|University of Washington|Johns Hopkins University | Alzheimer Disease | January 2001 | Phase 3 |
NCT05181124 | Onconic Therapeutics Inc. | Anti-Ulcer Agents | March 5, 2021 | Phase 1 |
NCT00435292 | Primus Pharmaceuticals | Osteoarthritis | April 2006 | Not Applicable |
NCT00662610 | NicOx | Osteoarthritis|Hypertension | March 2008 | Phase 1 |
NCT00751400 | Bayer|Pegus Research, Inc. | Pain | July 2008 | Phase 3 |
NCT00240773 | Johnson & Johnson Consumer and Personal Products Worldwide|McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | Osteoarthritis, Hip|Osteoarthritis, Knee | | Phase 3 |
NCT01231490 | GlaxoSmithKline | Osteoarthritis | September 2008 | Phase 2 |
NCT00830050 | Pfizer|King´s College London | Osteoarthritis | July 2010 | Early Phase 1 |
NCT01300546 | Cady, Roger, M.D.|GlaxoSmithKline | Migraine | December 2010 | Phase 4 |
NCT01147458 | Pfizer | Osteoarthritis, Knee | July 2010 | Phase 2 |
NCT00542555 | NicOx | Osteoarthritis | December 2005 | Phase 3 |
NCT00662896 | NicOx | Osteoarthritis|Hypertension | March 2008 | Phase 1 |
NCT02665286 | Montefiore Medical Center | Low Back Pain | March 2016 | Phase 4 |
NCT02501564 | Istanbul Medeniyet University|Abdi Ibrahim Ilac San. ve Tic A.S. | Osteoarthritis | May 2013 | Phase 4 |
NCT00392080 | Pfizer | Osteoarthritis | November 2006 | Phase 1 |
NCT02494856 | Giovana Maria Weckwerth|Fundação de Amparo à Pesquisa do Estado de São Paulo|University of Sao Paulo | Pain|Other Surgical Procedures|Impacted Third Molar Tooth | October 2014 | Phase 4 |
NCT00615875 | Hamilton Health Sciences Corporation|McMaster University | Pain, Postoperative | March 2008 | Phase 4 |
NCT01381523 | GlaxoSmithKline | Migraine Disorders | November 2010 | |
NCT00449787 | Montefiore Medical Center | Migraine|Tension-type Headache|Primary Headache Disorder | March 2007 | Phase 4 |
NCT01343303 | Janssen Research & Development, LLC | Osteoarthritis, Knee | March 2011 | Phase 1 |
NCT03654326 | Merck Sharp & Dohme LLC | Endometriosis-related Pain | September 11, 2018 | Phase 2 |
NCT00792636 | GlaxoSmithKline | Migraine Disorders | November 2008 | Phase 4 |
NCT00843024 | GlaxoSmithKline | Migraine Disorders | December 2008 | Phase 3 |
NCT02013427 | Northwestern University|National Center for Complementary and Integrative Health (NCCIH)|National Institutes of Health (NIH) | Chronic Low Back Pain | October 2014 | Phase 4 |
NCT00772967 | Merck Sharp & Dohme LLC | Osteoarthritis | June 2008 | Phase 1 |
NCT00442221 | POZEN | Migraine Headaches | May 2004 | Phase 3 |
NCT00175032 | Takeda | Osteoarthritis|Peptic Ulcer | July 2003 | Phase 3 |
NCT01165814 | Bnai Zion Medical Center | Pain|Cesarean Section | August 2006 | Not Applicable |
NCT03448536 | Bayer | Dysmenorrhea | April 5, 2018 | Phase 4 |
NCT00692055 | POZEN | Arthritis | June 2008 | Phase 1 |
NCT01090050 | Cady, Roger, M.D.|GlaxoSmithKline | Chronic Migraine | September 2010 | Phase 4 |
NCT01409603 | Astellas Pharma Inc | Pharmacodynamic Interaction|Healthy Subjects | January 2010 | Phase 1 |
NCT01131728 | Dr. Reddy´s Laboratories Limited | Healthy | July 2004 | Phase 1 |
NCT01381497 | GlaxoSmithKline | Migraine Disorders | March 2010 | |
NCT02500641 | Menarini International Operations Luxembourg SA | Gout | August 17, 2015 | Phase 4 |
NCT05504382 | Mohamed Abdelmoneim El Meligy|Egyptian Chinese University | Juvenile Rheumatoid Arthritis | August 1, 2022 | Not Applicable |
NCT02689024 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|ZonMw: The Netherlands Organisation for Health Research and Development | Hip Fractures|Anesthesia | May 2016 | Phase 4 |
NCT05900336 | Mclean Hospital|United States Department of Defense|NorthShore University HealthSystem | Dysmenorrhea|Menstrual Pain|Non-steroidal Anti-inflammatory Drug | September 1, 2023 | Phase 4 |
NCT00959439 | Sandoz | Rheumatoid Arthritis|Osteoarthritis | March 2002 | Phase 1 |
NCT01165307 | Abimbola Famuyide|Hologic, Inc.|Mayo Clinic | Menorrhagia | August 2009 | Phase 4 |
NCT02183038 | Boehringer Ingelheim | Pharyngitis | July 1998 | Phase 2 |
NCT00692016 | Bayer | Bioavailability | January 2008 | Phase 1 |
NCT01884272 | Ardea Biosciences, Inc. | Gout | June 2013 | Phase 1 |
NCT00602420 | Gary Morrow|National Cancer Institute (NCI)|University of Rochester | Musculoskeletal Complications|Pain|Unspecified Adult Solid Tumor, Protocol Specific | June 2008 | Phase 3 |
NCT04837014 | McGill University Health Centre+Research Institute of the McGill University Health Centre | Pain, Postoperative|Opioid Use | July 4, 2022 | Not Applicable |
NCT01951105 | Northwestern University|National Institutes of Health (NIH)|National Institute of Dental and Craniofacial Research (NIDCR) | Sub-acute Back Pain | February 24, 2015 | Phase 4 |
NCT00749385 | POZEN | Arthritis | August 2008 | Phase 1 |
NCT03396250 | Bayer | Pain | February 12, 2018 | Phase 1 |
NCT00092729 | Organon and Co | Dysmenorrhea | June 7, 2002 | Phase 3 |
NCT00863304 | Pfizer | Osteoarthritis | June 9, 2009 | Phase 3 |
NCT00584870 | Pfizer | Low Back Pain | July 5, 2007 | Phase 2 |
NCT00527787 | POZEN | Gastric Ulcer | September 2007 | Phase 3 |
NCT05430230 | Northwestern University | Osteoarthritis, Knee | August 24, 2022 | Phase 4 |
NCT04694300 | Hersh, Elliot V., DMD, MS, PhD|University of Pennsylvania | Osseointegrated Dental Implantation|Pain, Acute | February 7, 2021 | Phase 4 |
NCT01052129 | Dr. Reddy´s Laboratories Limited | Healthy | May 2006 | Phase 1 |
NCT01471899 | EMS | Back Pain | March 2013 | Phase 3 |
NCT01712009 | Amgen | Bone Pain in Stage I - III Breast Cancer | November 1, 2012 | Phase 2 |
NCT02262754 | Pfizer | Chronic Low Back Pain | October 2014 | Phase 2 |
NCT04948164 | Peking University Third Hospital|Jiangsu Provincial People´s Hospital|The First Affiliated Hospital of Guangzhou Medical University|Second Hospital of Jilin University|The Second Affiliated Hospital of Kunming Medical University|The Second Hospital of Nanjing Medical University|The Affiliated Hospital of Qingdao University|Beijing Friendship Hospital|West China Hospital|Second Affiliated Hospital of Wenzhou Medical University|The Third Xiangya Hospital of Central South University | Migraine in Adults | August 1, 2018 | Phase 3 |
NCT03879408 | Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division|Johnson & Johnson Consumer and Personal Products Worldwide | Pain | May 28, 2019 | Phase 2 |
NCT00720057 | Bayer | Toothache | June 2008 | Phase 3 |
NCT03570554 | Bayer | Osteoarthritis, Knee | June 29, 2018 | Phase 2 |
NCT03697889 | McNeil AB|Johnson & Johnson Consumer and Personal Products Worldwide | Healthy | December 3, 2018 | Phase 1 |
NCT03347929 | Ostfold Hospital Trust|Vestre Viken Hospital Trust|Sykehuset Telemark|Helse Stavanger HF|Oslo University Hospital | Sciatica | November 30, 2017 | Phase 4 |
NCT00367211 | POZEN | Osteoarthritis|Rheumatoid Arthritis|Ankylosing Spondylitis | September 2006 | Phase 3 |
NCT00672646 | AstraZeneca | Pain | April 2008 | Phase 2 |
NCT01587274 | Montefiore Medical Center | Acute Low Back Pain | April 2012 | Phase 4 |
NCT00933582 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Osteoarthritis, Knee | August 2009 | Phase 1 |
NCT02646124 | Montefiore Medical Center | Low Back Pain | June 2015 | Phase 2|Phase 3 |